Decheng Capital Management III as of Sept. 30, 2022
Portfolio Holdings for Decheng Capital Management III
Decheng Capital Management III holds 26 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpine Immune Sciences (ALPN) | 17.5 | $48M | 6.7M | 7.20 | |
| Zentalis Pharmaceuticals (ZNTL) | 14.3 | $40M | 1.8M | 21.66 | |
| Cue Health (HLTH) | 9.8 | $27M | 9.0M | 3.01 | |
| Illumina (ILMN) | 9.0 | $25M | 130k | 190.79 | |
| Arcus Biosciences Incorporated (RCUS) | 8.2 | $23M | 870k | 26.16 | |
| Prometheus Biosciences | 5.3 | $15M | 250k | 59.01 | |
| Albireo Pharma | 4.4 | $12M | 623k | 19.36 | |
| 10x Genomics Cl A Com (TXG) | 3.7 | $10M | 360k | 28.48 | |
| Equillium (EQ) | 3.6 | $9.9M | 4.4M | 2.22 | |
| Pacific Biosciences of California (PACB) | 3.1 | $8.5M | 1.5M | 5.81 | |
| Adicet Bio (ACET) | 3.0 | $8.2M | 580k | 14.22 | |
| Aadi Bioscience (AADI) | 2.7 | $7.4M | 526k | 14.13 | |
| Mersana Therapeutics (MRSN) | 2.2 | $6.1M | 904k | 6.76 | |
| Apexigen | 1.9 | $5.1M | 1.9M | 2.70 | |
| BeyondSpring SHS (BYSI) | 1.8 | $4.9M | 5.0M | 0.99 | |
| Horizon Therapeutics | 1.8 | $4.9M | 79k | 61.89 | |
| Terns Pharmaceuticals (TERN) | 1.5 | $4.2M | 714k | 5.89 | |
| Aura Biosciences (AURA) | 1.4 | $3.8M | 210k | 18.12 | |
| Seattle Genetics | 1.1 | $3.1M | 23k | 136.83 | |
| Sema4 Holings Corp. Com Cl A | 1.1 | $3.0M | 3.4M | 0.88 | |
| Argenx Se (ARGX) | 0.7 | $2.0M | 5.5k | 353.05 | |
| AtriCure | 0.7 | $1.8M | 46k | 39.11 | |
| Scynexis Com New (SCYX) | 0.5 | $1.3M | 556k | 2.40 | |
| Owlet Com Cl A | 0.3 | $961k | 898k | 1.07 | |
| Nautilus Biotechnology (NAUT) | 0.2 | $636k | 300k | 2.12 | |
| Neubase Therapeutics Ord | 0.1 | $395k | 1.0M | 0.40 |
